A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.

被引：0
|
作者：
Buckstein, Rena
Crump, Michael
Fraser, Graeme A.
Cheung, Matthew C.
Piliotis, Eugenia
Imrie, Kevin
Kukreti, Vishal
Kuruvilla, John
Meyer, Ralph M.
Windsor, Jolanta
Pond, Gregory Russell
Pritchard, Kathleen I.
Levine, Mark Norman
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada
[5] Juravinski Canc Ctr, Hamilton, ON, Canada
[6] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada
[7] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8551
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas
    Moon, J.
    Kim, J.
    Sohn, S.
    Yang, D.
    Lee, J.
    Kim, H.
    Shin, H.
    Chung, J.
    Lee, W.
    Joo, Y.
    Oh, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
    Jong Gwang Kim
    Sang Kyun Sohn
    Yee Soo Chae
    Yoon Young Cho
    Deok Hwan Yang
    Je-Jung Lee
    Hyeoung-Joon Kim
    Ho Jin Shin
    Joo Seop Chung
    Goon Jae Cho
    Won-Sik Lee
    Young-Don Joo
    Chang-Hak Sohn
    Suk Joong Oh
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 129 - 134
  • [3] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Chae, Yee Soo
    Cho, Yoon Young
    Yang, Deok Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    Shin, Ho Jin
    Chung, Joo Seop
    Cho, Goon Jae
    Lee, Won-Sik
    Joo, Young-Don
    Sohn, Chang-Hak
    Oh, Suk Joong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 129 - 134
  • [4] A pilot study of alemtuzumab plus combination chemotherapy for newly diagnosed patients with peripheral T-cell lymphomas.
    Kim, Jin Seok
    Kim, Soo-Jeong
    Lee, Hye Won
    Yoon, Sul Hee
    Park, In-Hae
    Kim, Yuri
    Cheong, June-Won
    Min, Yoo-Hong
    BLOOD, 2006, 108 (11) : 262B - 262B
  • [5] Peripheral T-cell lymphomas. Primary and relapsetreatment
    Wulf, G.
    Weber, T.
    ONKOLOGE, 2019, 25 (10): : 892 - 898
  • [6] A phase II immunochemotherapy study with alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD) in peripheral T-cell lymphomas.
    Weidmann, Eckhart
    Hess, Georg
    Krause, Stefan W.
    Subklewe, Marion
    Kruse, Judith
    Soekler, Martin
    Weisel, Katja
    Kim, Soo-Zin
    Dreyling, Martin H.
    Jager, Elke
    BLOOD, 2006, 108 (11) : 769A - 769A
  • [7] Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study
    Buckstein, Rena
    Fraser, Graeme
    Cheung, Matthew
    Kukreti, Vishal
    Kuruvilla, John
    Imrie, Kevin
    Piliotis, Eugenia
    Pond, Gregory
    Windsor, Jolanta
    Ghorab, Zeina
    Shuoprasad, Kevin
    Turner, Ruth
    Meyer, Ralph M.
    Pritchard, Kathy
    Walker, Scott
    Levine, Mark
    Crump, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (01): : 18 - 28
  • [8] Erythrophagocytic T-cell lymphomas are hepatosplenic γδ T-cell lymphomas.
    Macon, WR
    Przybylski, GK
    Salhany, KE
    Choi, JK
    Kadin, ME
    LABORATORY INVESTIGATION, 1999, 79 (01) : 142A - 142A
  • [9] Denileukin diftitox (ONTAK) plus CHOP chemotherapy in patients with peripheral T-Cell lymphomas (PTCL), the CONCEPT trial
    Foss, Francine
    Sjak-Shie, Nelida
    Goy, Andre
    Jacobsen, Eric
    Advani, Ranjana
    Smith, Mitchell
    Komrokji, Rami
    Pendergrass, Kelly
    Bolejack, Vanessa
    Watts, Karen
    Acosta, Mark
    BLOOD, 2007, 110 (11) : 1011A - 1011A
  • [10] Role of surveillance imaging in the management of peripheral T-cell lymphomas.
    Tang, Tiffany Pool Ling
    Chen, Zhengming
    Praditsuktavorn, Pannee
    Khoo, Lay Poh
    Ruan, Jia
    Lim, Soon Thye
    Tan, Daryl C. L.
    Diong, Colin
    Lee, Yuh Shan
    Tee, Goh Yeow
    Hwang, William
    Tao, Miriam
    Hui, Richard Hong
    Tay, Quek Kevin
    Farid, Mohamad
    Furman, Richard R.
    Leonard, John
    Martin, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345